Tahapan Flu

Tahapan Flu. The flu vaccine is a safe and effective vaccine It&#39s offered every year on the NHS to help protect people at risk of flu and its complications The best time to have the flu vaccine is in the autumn before flu starts spreading But you can get the vaccine later Who can have the flu vaccine.

The World Health Organisation (WHO) estimates that flu also has an IFR of 01 per cent or lower while New Zealand has put it at 0039 per cent – a little less than half.

Penyakit Flu Gejala, Penyebab, dan Cara Mengobati Halodoc.com

The original Omicron wave caused a large number of cases in December and into the new year However now a new subvariant known as BA2 has been identified in the UK A case was identified in.

Influenza vaccines: 2021 to 2022 flu season GOV.UK

Flu atau influenza ini sangat umum terjadi di musim pancaroba Penyakit ini sangat mudah menular ke orang lain terutama ketika 3–4 hari pertama setelah pengidapnya terinfeksi virus flu Gejalagejala flu yang biasa dirasakan pengidapnya adalah demam sakit kepala batukbatuk pegalpegal kehilangan nafsu makan serta sakit tenggorokan.

Flu NHS

Flu vaccines help protect against the main types of flu virus circulating The harm flu can do People sometimes think a bad cold is flu but having flu can often be much worse than a cold and you.

Etika Mencegah Penularan Influenza Di Tempat Umum

The National Influenza Immunisation Programme 2021 to 2022EligibilityAchieving High Vaccine Uptake LevelsInfluenza and Covid19 VaccinationConclusionLast year saw the roll out of the biggest NHS influenza vaccination programme ever with the aim of offering protection to as many eligible people as possible during the coronavirus (COVID19) pandemic We would like to extend a huge thank you to all those involved for your hard work during very challenging times which led to the best influenza vaccine uptake rates ever achieved As a result of nonpharmaceutical interventions in place for COVID19 (such as maskwearing physical and social distancing and restricted international travel) influenza activity levels were extremely low globally in 2020 to 2021 As a result a lower level of population immunity against influenza is expected in 2021 to 2022 In the situation where social mixing and social contact return towards prepandemic norms it is expected that winter 2021 to 2022 will be the first winter in the UK when seasonal influenza virus (and other respiratory viruses) will cocirculate alongside COVID19 Seasonal influenza The national influenza immunisation programme aims to provide direct protection to those who are at higher risk of influenza associated morbidity and mortality Groups eligible for influenza vaccination are based on the advice of the Joint Committee on Vaccination and Immunisation (JCVI) and include older people pregnant women and those with certain underlying medical conditions Since 2013 influenza vaccination has been offered to children in a phased rollout to provide both individual protection to the children themselves and reduce transmission across all age groups to protect vulnerable members of the population The expanded influenza vaccination programme that we had last year will continue in 2021 to 2022 as part of our wider winter planning when we are likely to see both influenza and COVID19 in circulation This means that as a temporary measure the offer for 50 to 64 year olds will continue this year to protect this age group as hospitalisation from COVID19 also inc Last season saw the most successful programme ever Despite the challenges due to the COVID19 pandemic at the end of February 2021 NHS services had vaccinated a record 809% of those aged 65 years and over in England This is the highest uptake ever achieved for this group and exceeds the WHO uptake ambition of 75% For frontline healthcare workers 2 and 3 year olds and at risk groups the highest ever recorded levels of influenza vaccine uptake were also achieved All providers should have planned their influenza vaccine ordering to at least equal the high levels of uptake achieved in 2020 to 2021 The ambitions we are setting for the 2021 to 2022 programme are set out below We want to build on the momentum of last year’s achievements and the successful rollout of the COVID19 vaccination programme achieving even higher uptake this year You many need to order additional vaccine to support you in reaching these ambitions The high ambitions reflect the importance of protectin Booster vaccines for COVID19 are currently under consideration with trials underway to ascertain whether coadministration of COVID19 and influenza vaccines will be permissible subject to the advice of JCVI Early evidence on the concomitant administration of COVID19 and influenza vaccines used in the UK supports the delivery of both vaccines at the same timewhere appropriate Planning for influenza vaccination should continue as usual for this autumn with further advice issued should coadministration with COVID19 vaccination be recommended so that where appropriate both vaccines could be given at the same time We would like to take this opportunity to thank you all for your hard work in delivering the influenza immunisation programme We have some of the best influenza vaccine uptake rates in Europe and we achieved record levels in 2020 to 2021 This winter it remains a key intervention to reduce pressure on the NHS and social care This Annual Influenza Letter has the support of the Chief Pharmaceutical Officer the NHS Chief Nursing Officer for England and the Public Health England Chief Nurse Prof Chris Whitty Chief Medical Officer for England Prof Yvonne Doyle Public Health England Medical Director and Director for Health Protection Prof Stephen Powis NHS England and NHS Improvement National Medical Director Any enquiries regarding this publication should be sent to immunisation@phegovuk For operational immunisation queries providers should contact their local screening and immunisation team.